메뉴 건너뛰기
JAMA: The Journal of the American Medical Association
Volumn 275, Issue 14, 1996, Pages 1086-
Pharmacies and Prevention of Potentially Fatal Drug Interactions
Author keywords

[No Author keywords available]
Indexed keywords

ERYTHROMYCIN; KETOCONAZOLE; TERFENADINE;
EID: 0029968234     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1996.03530380028022     Document Type: Letter
Times cited : (93)
References (3)
  • 1
    • 0029066463 scopus 로고
    • Incidence of adverse drug events and potential adverse events: implications for prevention
    • Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse events: implications for prevention. JAMA. 1995;274:29-34.
    • (1995) JAMA. , vol.274 , pp. 29-34
    • Bates, D.W.1    Cullen, D.J.2    Laird, N.3
  • 2
    • 0028978123 scopus 로고
    • Systems analysis of adverse drug events
    • Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA. 1995;274:35-43.
    • (1995) JAMA. , vol.274 , pp. 35-43
    • Leape, L.L.1    Bates, D.W.2    Cullen, D.J.3
  • 3
    • 0027474601 scopus 로고
    • Mechanism of the cardiotoxic actions of terfenadine
    • Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA. 1993;269:1532-1536.
    • (1993) JAMA. , vol.269 , pp. 1532-1536
    • Woosley, R.L.1    Chen, Y.2    Freiman, J.P.3    Gillis, R.A.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.